Nature Communications (Apr 2020)

Developing a new class of engineered live bacterial therapeutics to treat human diseases

  • Mark R. Charbonneau,
  • Vincent M. Isabella,
  • Ning Li,
  • Caroline B. Kurtz

DOI
https://doi.org/10.1038/s41467-020-15508-1
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

The role microbes play in human health and the ability of synthetic biology to engineer microbial properties opens up new ways of treating disease. In this perspective, the authors describe the design and development of these living therapeutics.